STOCK TITAN

Wellington Group Holds 10.2% Stake in Acadia Healthcare via Clients

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Wellington Management and related entities report beneficial ownership of 9,423,548 shares of Acadia Healthcare Company, Inc. common stock, representing 10.2% of the class as of the event date 09/30/2025. The filing is a Schedule 13G amendment listing four Wellington-related filers organized in Massachusetts and Delaware. The reported holdings show no sole voting or dispositive power and instead reflect shared voting power of 8,982,886 shares and shared dispositive power of 9,423,548 shares, indicating these securities are owned of record by Wellington clients and managed by its investment advisers. The filing names one client exceeding a 5% threshold: the Vanguard Health Care Fund. Signatures are provided by a Wellington regulatory analyst on 10/07/2025.

Positive

  • Material passive stake of 9,423,548 shares representing 10.2%
  • Position held in ordinary course (Schedule 13G), indicating no stated intent to change control
  • Clear disclosure of shared voting and dispositive powers and client ownership structure

Negative

  • No sole voting power reported (0 shares), indicating no unilateral control
  • Shared voting power concentration may limit ability to influence corporate decisions despite >5% ownership

Insights

Wellington holds a material passive stake of 10.2% in ACHC through shared authority.

Wellington and affiliated entities collectively report ownership of 9,423,548 shares, equal to 10.2% of the outstanding common stock. The position is reported on Schedule 13G, which signals a passive investor status rather than an active change-of-control intent.

The filing discloses 0 shares of sole voting or dispositive power while listing 8,982,886 shares with shared voting power, showing decision authority rests across advisers and clients. Monitor any future amendments or Schedule 13D filings within a typical 45–90 day window for shifts from passive to active involvement.

The stake is material but structured as client-owned holdings under advisory control, limiting single‑entity control.

The investors named are holding companies and investment adviser entities; ownership is held of record by clients of the Wellington Investment Advisers and one client (Vanguard Health Care Fund) is identified as exceeding 5% where applicable. This structure explains the shared voting and shared dispositive powers rather than sole control.

For governance impact, the current filing implies limited ability to unilaterally influence board composition or corporate actions. Watch for any disclosures of coordinated voting agreements or a switch to a Schedule 13D if involvement changes in the near term.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:10/07/2025
Wellington Group Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:10/07/2025
Wellington Investment Advisors Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:10/07/2025
Wellington Management Company LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:10/07/2025

FAQ

What stake does Wellington report in Acadia Healthcare (ACHC)?

Wellington and affiliated entities report beneficial ownership of 9,423,548 shares, equal to 10.2% of Acadia Healthcare common stock as of 09/30/2025.

Does Wellington have voting control over ACHC shares?

No sole voting power is reported (0 shares). The filing shows shared voting power of 8,982,886 shares and shared dispositive power for 9,423,548 shares.

Is this filing a Schedule 13G or 13D and what does that mean for ACHC investors?

This is a Schedule 13G (amendment), which indicates the position is reported as passive and not intended to change or influence control of the issuer.

Are any underlying clients owning more than 5% disclosed?

Yes, the filing identifies the Vanguard Health Care Fund as a client relevant to the >5% disclosure.

When were the signatures dated on the filing?

Signatures by a Wellington regulatory analyst are dated 10/07/2025 on the amended Schedule 13G.
Acadia Healthcar

NASDAQ:ACHC

ACHC Rankings

ACHC Latest News

ACHC Latest SEC Filings

ACHC Stock Data

1.44B
90.53M
1.78%
116.36%
12.82%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States
FRANKLIN